Structure-activity relationships of multidrug resistance reversers M Wiese, IK Pajeva Current medicinal chemistry 8 (6), 685-713, 2001 | 235 | 2001 |
Structure–activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP) A Pick, H Müller, R Mayer, B Haenisch, IK Pajeva, M Weigt, H Bönisch, ... Bioorganic & medicinal chemistry 19 (6), 2090-2102, 2011 | 232 | 2011 |
Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis) IK Pajeva, M Wiese Journal of medicinal chemistry 45 (26), 5671-5686, 2002 | 216 | 2002 |
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors S Dallavalle, V Dobričić, L Lazzarato, E Gazzano, M Machuqueiro, ... Drug Resistance Updates 50, 100682, 2020 | 197 | 2020 |
Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: a comparative molecular field analysis study I Pajeva, M Wiese Journal of medicinal chemistry 41 (11), 1815-1826, 1998 | 128 | 1998 |
Computational studies of free radical-scavenging properties of phenolic compounds P Alov, I Tsakovska, I Pajeva Current topics in medicinal chemistry 15 (2), 85-104, 2015 | 117 | 2015 |
Combined pharmacophore modeling, docking, and 3D QSAR studies of ABCB1 and ABCC1 transporter inhibitors IK Pajeva, C Globisch, M Wiese ChemMedChem: Chemistry Enabling Drug Discovery 4 (11), 1883-1896, 2009 | 110 | 2009 |
Identification of putative binding sites of P‐glycoprotein based on its homology model C Globisch, IK Pajeva, M Wiese ChemMedChem: Chemistry Enabling Drug Discovery 3 (2), 280-295, 2008 | 107 | 2008 |
Structure− function relationships of multidrug resistance P-glycoprotein IK Pajeva, C Globisch, M Wiese Journal of medicinal chemistry 47 (10), 2523-2533, 2004 | 103 | 2004 |
Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability IK Pajeva, M Wiese, HP Cordes, JK Seydel Journal of cancer research and clinical oncology 122, 27-40, 1996 | 103 | 1996 |
Quantitative structure-skin permeability relationships I Tsakovska, I Pajeva, M Al Sharif, P Alov, E Fioravanzo, S Kovarich, ... Toxicology 387, 27-42, 2017 | 101 | 2017 |
Interactions of poly (vinylpyrrolidone) with ibuprofen and naproxen: experimental and modeling studies S Bogdanova, I Pajeva, P Nikolova, I Tsakovska, B Müller Pharmaceutical research 22, 806-815, 2005 | 89 | 2005 |
New functional assay of P-glycoprotein activity using Hoechst 33342 H Müller, W Klinkhammer, C Globisch, MU Kassack, IK Pajeva, M Wiese Bioorganic & medicinal chemistry 15 (23), 7470-7479, 2007 | 73 | 2007 |
Functional assay and structure–activity relationships of new third-generation P-glycoprotein inhibitors H Müller, IK Pajeva, C Globisch, M Wiese Bioorganic & medicinal chemistry 16 (5), 2448-2462, 2008 | 72 | 2008 |
Repurposing old drugs to fight multidrug resistant cancers J Dinić, T Efferth, AT García-Sosa, J Grahovac, JM Padrón, I Pajeva, ... Drug Resistance Updates 52, 100713, 2020 | 70 | 2020 |
Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators W Klinkhammer, H Müller, C Globisch, IK Pajeva, M Wiese Bioorganic & medicinal chemistry 17 (6), 2524-2535, 2009 | 65 | 2009 |
Structure–activity relationships of a series of tariquidar analogs as multidrug resistance modulators C Globisch, IK Pajeva, M Wiese Bioorganic & medicinal chemistry 14 (5), 1588-1598, 2006 | 61 | 2006 |
AMMOS: Automated Molecular Mechanics Optimization tool for in silico Screening T Pencheva, D Lagorce, I Pajeva, BO Villoutreix, MA Miteva BMC bioinformatics 9, 1-15, 2008 | 58 | 2008 |
QSAR and molecular modelling of catamphiphilic drugs able to modulate multidrug resistance in tumors IK Pajeva, M Wiese Quantitative Structure‐Activity Relationships 16 (1), 1-10, 1997 | 53 | 1997 |
Structure–activity relationships of tariquidar analogs as multidrug resistance modulators IK Pajeva, M Wiese The AAPS journal 11, 435-444, 2009 | 51 | 2009 |